🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11703+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11703 recruiting trials

RecruitingNCT06742073

Histiocytosis and Inflammatory Manifestations in Patients with H Syndrome

👨‍⚕️ Sarah Elitzur, MD, Schneider Children'ds Medical Center📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06396325

A Registry Based Randomized-Controlled Trial of an Upper Limb Exergaming Intervention for Children and Adolescents With Spinal Muscular Atrophy

👨‍⚕️ Maryam Oskoui, McGill University📍 5 sites📅 Started Nov 2024View details ↗
RecruitingNCT06452732

Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML

🏥 Peking University People's Hospital📍 2 sites📅 Started Nov 2024View details ↗
RecruitingNCT07070362

Digital Early Warning System for Acute Lung Injury in Liver Surgery

🏥 Beijing Tsinghua Chang Gung Hospital📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06646497

Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years

🏥 Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Nov 2024View details ↗
Enrolling by InvitationNCT05102981

Function and Quality of Life After Emergency vs Planned Creation of a Stoma

🏥 Eva Haglind, MD, PhD, professor📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT06727669

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

👨‍⚕️ Xiao-Hui Zhang, MD, Peking University Institute of Hematology, Peking University People's Hospital📍 5 sites📅 Started Nov 2024View details ↗
RecruitingNCT06657846

HRQoL and Financial Toxicity in Patients With VEXAS Syndrome

🏥 Gruppo Italiano Malattie EMatologiche dell'Adulto📍 17 sites📅 Started Nov 2024View details ↗
Enrolling by InvitationNCT06598709

International Survey for EXTubation Evaluation and Respiratory Dynamics in Acute Respiratory Distress Syndrome

🏥 Hiroshima University📍 1 site📅 Started Nov 2024View details ↗
Phase 1RecruitingNCT06515990

A Study of DM005 in Patients With Advanced Solid Tumors

🏥 Doma Biopharmaceutical(Suzhou)Co., Ltd.📍 6 sites📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06699472

A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib

🏥 Fudan University📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT07083973

Prone Position Assessed by 3D EIT

🏥 Peking Union Medical College Hospital📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT06582199

Precision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCogBank-AD

👨‍⚕️ Emmanuel GOGNAT, MD, PhD, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT06565481

Measurement Properties in People with Hemophilia

👨‍⚕️ Ruud Knols, PhD, University of Zurich📍 1 site📅 Started Oct 2024View details ↗
Phase 1RecruitingNCT06732492

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

🏥 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06741722

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Based DCMG Regimen for R/R AML

🏥 Beijing 302 Hospital📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT06519175

Study of Infantile Lower Limb Malformations and Deformities

👨‍⚕️ Pierfrancesco Costici, MD, Ospedale Pediatrico Bambin Gesù📍 7 sites📅 Started Oct 2024View details ↗
RecruitingNCT06702579

Home Monitoring in Hemophilia a

🏥 Radboud University Medical Center📍 1 site📅 Started Oct 2024View details ↗
Phase 1RecruitingNCT06602232

A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo

👨‍⚕️ Michael Rothenberg, MD, PhD, Dren Bio📍 20 sites📅 Started Oct 2024View details ↗
NARecruitingNCT06615206

A First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of a Novel CRISPR RNA-editing Therapy in Patients with Mecp2 Duplication Syndrome, a Rare Orphan Disease (HERO)

👨‍⚕️ Study Director📍 1 site📅 Started Oct 2024View details ↗
← PreviousPage 215 of 586Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →